Intended Audience: All neonatal nurses

NCC Category Codes: NIC2; NNP2

Objectives: Upon completion, learners will be able to:

Describe the pathophysiology of 22q11.2 deletion syndrome (DS).
Outline the clinical manifestations of 22q11.2 DS.
Discuss the diagnosis and management of neonates with 22q11.2 DS.

Learning Outcome:

The learner will gain knowledge of the pathophysiology, presentation, and recommended testing for neonates with suspected 22q11.2 deletion syndrome (DiGeorge) to enhance early recognition of this condition.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

Pass the posttest with a score of 80%
Complete and submit the evaluation for this CNE activity

Accreditation
The Academy of Neonatal Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218.

Release Date: May/June 2023
Expiration Date: June 30, 2026

Disclosures:

The authors, nurse planner, planning committee, and the test review panel have no relevant financial relationships with any ineligible companies that may be related to the subjects discussed within this article.
Neither ANN nor the American Nurses Credentialing Center (ANCC) endorses any commercial products discussed/displayed in conjunction with this educational activity.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.

Laura Cline MSN, APRN, NNP

Appearances